Position in LLY
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$2,667,532
+$612,766 QoQ
Shares Held
2,224
-0.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
#2,235
of 4,605 holders
Holding Since
Dec 2021
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Scott & Selber, Inc. holds $15,126,614 across 6 Drug Manufacturers - General names. LLY ranks #3 (17.6% of the industry book) .
All Filings in LLY
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,667,532 | 2,224 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $2,054,766 | 2,234 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $2,410,507 | 2,243 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $1,644,265 | 2,155 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $1,666,635 | 2,138 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $1,750,929 | 2,120 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $1,636,640 | 2,120 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,877,306 | 2,119 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $1,932,080 | 2,134 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $1,648,497 | 2,119 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $1,241,619 | 2,130 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $1,147,309 | 2,136 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $1,002,210 | 2,137 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $727,706 | 2,119 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $773,385 | 2,114 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $674,184 | 2,085 | Shares | Sole | 2022-10-21 | |
| 2021-12-31 | $883,904 | 3,200 | Shares | Sole | 2022-02-04 | |
| No filing history on record for this holder in this stock. | ||||||